An Outbreak of Adenovirus Type 7 in a Residential Facility for Severely Disabled Children

Background: Adenoviruses cause a variety of clinical symptoms, involving the respiratory, gastrointestinal, urogenital, and neurologic systems. Only a few of the 55 known serotypes of adenovirus that affect humans can cause outbreaks of respiratory tract infection. Aim: To describe the characteristics and clinical manifestations of severe respiratory disease contracted by 8 physically and cognitively disabled children during a very short outbreak of adenovirus serotype 7 infection in a residential facility. Methods: The clinical, imaging, and laboratory findings of the patients who were hospitalized with severe respiratory symptoms were retrospectively reviewed. Molecular typing of the adenovirus was performed. Results: During 10 days in February 2010, 8 severely disabled children, 9 months to 5 years of age (median 22.5 months), from the same residential facility, were hospitalized due to severe acute respiratory disease with hypoxemia. Four of them (50%) needed mechanical ventilation for 2 to 8 days and one developed multisystem failure, including acute renal failure. Adenovirus serotype 7 was detected in the respiratory specimens of all 8 children. Two patients were treated with intravenous cidofovir. All 8 patients survived and were discharged after hospitalization of 6 to 15 (median: 11.5) days. The epidemiologic investigation revealed that all the 8 affected children shared a playroom and a caregiver worked with them while suffering fever, sore throat, and conjunctivitis before the onset of the outbreak. Conclusions: Adenovirus type 7 may cause short outbreaks of infection in institutions, causing children to develop life-threatening disease. Early detection of pathogens causing respiratory infections in institutions, isolation, and other preventive precautions are advocated. Moreover, vaccination of health care providers in institutions with the currently available live, oral adenovirus vaccine for types 4 and 7 should be considered.

[1]  N. Taveira,et al.  Outbreak of Acute Respiratory Infection among Infants in Lisbon, Portugal, Caused by Human Adenovirus Serotype 3 and a New 7/3 Recombinant Strain , 2010, Journal of Clinical Microbiology.

[2]  D. Seto,et al.  Computational Analysis Identifies Human Adenovirus Type 55 as a Re-Emergent Acute Respiratory Disease Pathogen , 2009, Journal of Clinical Microbiology.

[3]  Allen R. Chen,et al.  A Clinical Algorithm Identifies High Risk Pediatric Oncology and Bone Marrow Transplant Patients Likely to Benefit From Treatment of Adenoviral Infection , 2009, Journal of pediatric hematology/oncology.

[4]  H. Ishiko,et al.  Spread of Epidemic Keratoconjunctivitis Due to a Novel Serotype of Human Adenovirus in Japan , 2009, Journal of Clinical Microbiology.

[5]  J. Dawson,et al.  Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Roderick C. Jones,et al.  Outbreak of human adenovirus type 3 infection in a pediatric long-term care facility--Illinois, 2005. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Xing Lu,et al.  Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene , 2006, Archives of Virology.

[8]  M. Boeckh,et al.  ADENOVIRUS NEPHRITIS IN HEMATOPOIETIC STEM-CELL TRANSPLANTATION , 2004, Transplantation.

[9]  Z. Samra,et al.  Adenovirus Infection in Hospitalized Immunocompetent Children , 2004, Clinical pediatrics.

[10]  J. Ackelsberg,et al.  Adenovirus Type 7 Genomic-Type Variant, New York City, 1999 , 2004, Emerging infectious diseases.

[11]  L. Memi,et al.  Acute necrotizing tubulointerstitial nephritis due to systemic adenoviral infection , 2001, Pediatric Nephrology.

[12]  Roderick C. Jones,et al.  Outbreak of adenovirus genome type 7d2 infection in a pediatric chronic-care facility and tertiary-care hospital. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  M. Peuchmaur,et al.  Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children , 2001, Bone Marrow Transplantation.

[14]  F. Barrett,et al.  Adenovirus 7a: a community-acquired outbreak in a children’s hospital , 2000, The Pediatric infectious disease journal.

[15]  G. Gray,et al.  Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. For the Adenovirus Surveillance Group. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  T. Uemura,et al.  A Recent Outbreak of Adenovirus Type 7 Infection in a Chronic Inpatient Facility for the Severely Handicapped , 2000, Infection Control & Hospital Epidemiology.

[17]  H. Sakata,et al.  Outbreak of severe infection due to adenovirus type 7 in a paediatric ward in Japan. , 1998, The Journal of hospital infection.

[18]  J. C. Martin,et al.  Cidofovir, a New Agent with Potent Anti-Herpesvirus Activity , 1996 .

[19]  H. Cushing,et al.  Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin. , 1993, Bone marrow transplantation.

[20]  K. Bojang,et al.  Toxic shock-like syndrome caused by adenovirus infection. , 1992, Archives of disease in childhood.

[21]  G. Alpert,et al.  Outbreak of fatal adenoviral type 7a respiratory disease in a children's long-term care inpatient facility. , 1986, American journal of infection control.

[22]  D. Porter,et al.  Adenovirus infection in the immunocompromised patient. , 1980, The American journal of medicine.

[23]  P. Middleton Viral Infections of Humans. Epidemiology and Control. , 1978 .

[24]  P. N. Swift,et al.  ADENOVIRUS TYPE 7; 1971-74 , 1976, The Lancet.

[25]  C. Marsden,et al.  Letter: Bromocriptine in parkinsonism. , 1975, Lancet.

[26]  W. Gooch,et al.  Simultaneous oral administration of live adenovirus types 4 and 7 vaccines. Protection and lack of emergence of other types. , 1972, Archives of environmental health.

[27]  E. Buescher,et al.  Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines. , 1971, American journal of epidemiology.

[28]  R. Chanock,et al.  Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. , 1969, American journal of epidemiology.

[29]  G. Jackson,et al.  Mass enteric live adenovirus vaccination during epidemic ARD. , 1968, JAMA.

[30]  C. Chany,et al.  Severe and fatal pneumonia in infants and young children associated with adenovirus infections. , 1958, American journal of hygiene.

[31]  Ph.D. Joseph Heitman M.D.,et al.  Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2004, Mycopathologia.

[32]  J. Griffin,et al.  Live and inactivated adenovirus vaccines. Clinical evaluation of efficacy in prevention of acute respiratory disease. , 1970, Archives of internal medicine.

[33]  J. Gonnella,et al.  A nondirective approach to clinical instruction in medical school. , 1968, JAMA.